Breaking the Smoking Cycle: New Hope for People with Severe Mental Illness
The KISMET study suggests that a comprehensive one-year smoking cessation intervention may be effective in helping people with severe mental illness quit smoking, with significantly higher smoking cessation rates at 3 and 12 months compared to treatment as usual [1].
Smoking is a major public health concern, and people with severe mental illness are disproportionately affected, with smoking rates often twice as high as the general population. This vulnerability is due to a combination of factors, including the self-medication of symptoms, social and environmental influences, and the lack of access to effective smoking cessation programs. As a result, people with severe mental illness are at a higher risk of developing smoking-related illnesses, such as heart disease, lung cancer, and chronic obstructive pulmonary disease (COPD). The economic burden of smoking is also significant, with estimates suggesting that smoking-related illnesses cost the healthcare system billions of dollars each year.
The importance of addressing smoking in people with severe mental illness cannot be overstated. Not only can quitting smoking improve overall health and well-being, but it can also reduce the risk of premature death and improve mental health outcomes. However, quitting smoking can be challenging, especially for people with severe mental illness, who may face additional barriers such as cognitive impairment, lack of motivation, and social isolation. Therefore, there is a need for effective smoking cessation interventions that are tailored to the unique needs of this population. The KISMET study aimed to address this need by evaluating the effectiveness of a comprehensive one-year smoking cessation intervention for people with severe mental illness.
The KISMET study found that the intervention, which included cognitive-behavioral and peer support, combined with optional pharmacological treatment, was effective in helping people with severe mental illness quit smoking [1]. The study reported significantly higher smoking cessation rates at 3 and 12 months in the intervention group compared to the treatment as usual group. At 3 months, the odds of quitting smoking were 12 times higher in the intervention group, and at 12 months, the odds were 4 times higher [1]. These findings suggest that the KISMET intervention may be a useful addition to existing smoking cessation programs for people with severe mental illness.
The study also examined the impact of the intervention on secondary outcomes, including depression and anxiety, severity of psychotic symptoms, quality of life, disease self-management, lipid profile, blood pressure, body mass index, glucose level, and physical fitness [1]. However, the study found no significant differences between the intervention and treatment as usual groups on these outcomes. The high dropout rates in the study, particularly in the intervention group, may have limited the ability to detect significant differences in these outcomes. Despite these limitations, the study provides valuable insights into the effectiveness of the KISMET intervention and highlights the need for further research to optimize smoking cessation programs for people with severe mental illness.
The clinical implications of the KISMET study are significant, as they suggest that a comprehensive smoking cessation intervention can be effective in helping people with severe mental illness quit smoking [1]. This has important implications for healthcare providers, who can use this information to inform their treatment decisions and provide evidence-based care to their patients. The study also highlights the importance of addressing smoking in people with severe mental illness, as it can have a significant impact on overall health and well-being.
The KISMET study was a pragmatic cluster-randomized controlled trial that included 21 outpatient mental healthcare teams in the Netherlands [1]. The study collected data between October 2022 and July 2024 and used a combination of self-reported and objective measures to assess smoking cessation and secondary outcomes. The study's methodology was designed to reflect real-world practice and provide valuable insights into the effectiveness of the KISMET intervention in a clinical setting.
In practical terms, the KISMET study suggests that people with severe mental illness who want to quit smoking may benefit from a comprehensive smoking cessation intervention that includes cognitive-behavioral and peer support, combined with optional pharmacological treatment [1]. However, it is essential to note that quitting smoking is a complex process that requires individualized support and guidance. Readers who are interested in quitting smoking should consult their healthcare provider to discuss the best approach for their unique needs and circumstances. By working together with their healthcare provider, people with severe mental illness can develop a personalized quit plan that takes into account their physical and mental health needs, and increases their chances of success.
